Bajaj, Devendra; Geissler, Joseph R; Allen, Matthew R et al. (2016) Response to Courtney et al. Bone 89:77-79
|
Acevedo, Claire; Bale, Hrishikesh; Gludovatz, Bernd et al. (2015) Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone. Bone 81:352-363
|
Bajaj, Devendra; Geissler, Joseph R; Allen, Matthew R et al. (2014) The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate. Bone 64:57-64
|
Gallant, Maxime A; Brown, Drew M; Organ, Jason M et al. (2013) Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone 53:301-5
|
Green, J O; Diab, T; Allen, M R et al. (2012) Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated with trabecular microdamage initiation beyond those at 1 year. Osteoporos Int 23:2313-20
|
Gourion-Arsiquaud, Samuel; Allen, Matthew R; Burr, David B et al. (2010) Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone 46:666-72
|
Siegmund, Thomas; Allen, Matthew R; Burr, David B (2010) Can deterministic mechanical size effects contribute to fracture and microdamage accumulation in trabecular bone? J Theor Biol 265:202-10
|
O'Neal, Jessica M; Diab, Tamim; Allen, Matthew R et al. (2010) One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation. Bone 47:241-7
|
Imel, Erik A; DiMeglio, Linda A; Hui, Siu L et al. (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846-50
|
Allen, Matthew R; Erickson, Antonia M; Wang, Xiang et al. (2010) Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Calcif Tissue Int 86:67-71
|
Showing the most recent 10 out of 50 publications